Published in J AIDS Clin Res on August 04, 2012
Male migrants' non-spousal sexual partnerships in the place of origin: an in-depth investigation in two rural settings of India. Cult Health Sex (2013) 0.81
The role of Human Papilloma Virus (HPV) vaccination in the prevention of anal cancer in individuals with Human Immunodeficiency Virus-1 (HIV-1) infection. Ther Adv Vaccines (2013) 0.77
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet (2009) 6.96
Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med (2009) 4.34
Migration, settlement change and health in post-apartheid South Africa: triangulating health and demographic surveillance with national census data. Scand J Public Health Suppl (2007) 3.72
Sexual violence and its health consequences for female children in Swaziland: a cluster survey study. Lancet (2009) 2.80
Characteristics associated with HIV infection among heterosexuals in urban areas with high AIDS prevalence --- 24 cities, United States, 2006-2007. MMWR Morb Mortal Wkly Rep (2011) 2.59
Migration and AIDS. Int Migr (1998) 2.52
Striving against adversity: the dynamics of migration, health and poverty in rural South Africa. Glob Health Action (2010) 2.50
Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection. J Infect Dis (2011) 2.34
Global prevention of HIV infection for neglected populations: men who have sex with men. Clin Infect Dis (2010) 1.70
Cultural politics and masculinities: Multiple-partners in historical perspective in KwaZulu-Natal. Cult Health Sex (2006) 1.67
Challenging urban health: towards an improved local government response to migration, informal settlements, and HIV in Johannesburg, South Africa. Glob Health Action (2011) 1.66
Gender inequitable masculinity and sexual entitlement in rape perpetration South Africa: findings of a cross-sectional study. PLoS One (2011) 1.57
Transactional relationships and sex with a woman in prostitution: prevalence and patterns in a representative sample of South African men. BMC Public Health (2012) 1.53
Urban health in Johannesburg: the importance of place in understanding intra-urban inequalities in a context of migration and HIV. Health Place (2010) 1.50
The relationship between intimate partner violence, rape and HIV amongst South African men: a cross-sectional study. PLoS One (2011) 1.47
Cultural politics and masculinities: multiple-partners in historical perspective in KwaZulu-Natal. Cult Health Sex (2005) 1.42
Psychiatric issues in the management of patients with HIV infection. JAMA (2001) 1.25
Dialectical theory and the study of HIV/AIDS and other epidemics. Dialect Anthropol (2011) 1.11
Depressive symptoms and their impact on health-seeking behaviors in newly-diagnosed HIV-infected patients in Durban, South Africa. AIDS Behav (2012) 1.08
Prospective study of rape perpetration by young South African men: incidence & risk factors. PLoS One (2012) 1.06
Learning from HIV: exploring migration and health in South Africa. Glob Public Health (2011) 1.06
Stigma, prejudice and discrimination in global public health. Cad Saude Publica (2012) 0.95
Virginity testing: managing sexuality in a maturing HIV/AIDS epidemic. Med Anthropol Q (2001) 0.87
Cattle for Wives and Extramarital Trysts for Husbands? Lobola, Men, and HIV/STD Risk Behavior in Southern Africa. J Hum Behav Soc Environ (2011) 0.77
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. Cell Host Microbe (2008) 4.55
Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study. J Infect Dis (2009) 3.48
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals. Nat Med (2008) 2.94
Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. Proc Natl Acad Sci U S A (2008) 2.38
Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals. AIDS (2010) 1.80
Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007. J Infect Dis (2009) 1.78
Outcomes after virologic failure of first-line ART in South Africa. AIDS (2010) 1.74
Virologic response differences between African Americans and European Americans initiating highly active antiretroviral therapy with equal access to care. J Acquir Immune Defic Syndr (2009) 1.70
HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles. PLoS One (2008) 1.69
Increasing age at HIV seroconversion from 18 to 40 years is associated with favorable virologic and immunologic responses to HAART. J Acquir Immune Defic Syndr (2008) 1.66
High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen. AIDS (2012) 1.60
HIV treatment adherence, drug resistance, virologic failure: evolving concepts. Infect Disord Drug Targets (2011) 1.53
The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry. Blood (2009) 1.51
Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States. Ann Intern Med (2015) 1.47
In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine. J Virol (2008) 1.45
Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations. J Virol Methods (2007) 1.43
Anal cancers among HIV-infected persons: HAART is not slowing rising incidence. AIDS (2010) 1.39
Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States: late versus early diagnosis and entry into care. J Acquir Immune Defic Syndr (2013) 1.19
CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy. Clin Infect Dis (2010) 1.18
Role of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy. PLoS One (2008) 1.15
Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort. AIDS Res Ther (2011) 1.11
Responsiveness of T cells to interleukin-7 is associated with higher CD4+ T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced viral load suppression. J Infect Dis (2009) 1.08
Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomes. J Infect Dis (2013) 1.07
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine. J Infect Dis (2013) 1.06
Effect of HAART on incident cancer and noncancer AIDS events among male HIV seroconverters. J Acquir Immune Defic Syndr (2008) 1.04
CCL3L1-CCR5 genotype improves the assessment of AIDS Risk in HIV-1-infected individuals. PLoS One (2008) 1.02
A comparison of HAART outcomes between the US military HIV Natural History Study (NHS) and HIV Atlanta Veterans Affairs Cohort Study (HAVACS). PLoS One (2013) 1.00
Clinical evaluation of the potential utility of computational modeling as an HIV treatment selection tool by physicians with considerable HIV experience. AIDS Patient Care STDS (2011) 0.95
The continuum of HIV care in a Veterans' Affairs clinic. AIDS Res Hum Retroviruses (2014) 0.90
Early postseroconversion CD4 cell counts independently predict CD4 cell count recovery in HIV-1-postive subjects receiving antiretroviral therapy. J Acquir Immune Defic Syndr (2011) 0.90
The effect of human immunodeficiency virus on hepatitis B virus serologic status in co-infected adults. PLoS One (2010) 0.89
Health care transmission of a newly emergent adenovirus serotype in health care personnel at a military hospital in Texas, 2007. J Infect Dis (2009) 0.89
Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations. J Infect Dis (2008) 0.88
Treatment-mediated alterations in HIV fitness preserve CD4+ T cell counts but have minimal effects on viral load. PLoS Comput Biol (2010) 0.88
Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy. J Acquir Immune Defic Syndr (2011) 0.86
Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrations. J Clin Pharmacol (2014) 0.85
The global status of HIV drug resistance: clinical and public-health approaches for detection, treatment and prevention. Infect Disord Drug Targets (2011) 0.84
Concurrent use of traditional medicine and ART: Perspectives of patients, providers and traditional healers in Durban, South Africa. Glob Public Health (2014) 0.84
Impact of protease inhibitors on intracellular concentration of tenofovir-diphosphate among HIV-1 infected patients. AIDS (2015) 0.84
Antiretroviral reduction: is it time to rethink the unthinkable? AIDS (2014) 0.83
Treatment options after virological failure of first-line tenofovir-based regimens in South Africa: an analysis by deep sequencing. AIDS (2016) 0.82
Gender-specific risk factors for virologic failure in KwaZulu-Natal: automobile ownership and financial insecurity. AIDS Behav (2014) 0.81
Coadministration of lopinavir/ritonavir and rifampicin in HIV and tuberculosis co-infected adults in South Africa. PLoS One (2012) 0.81
Occupational exposure to blood and other bodily fluids at a military hospital in Iraq. J Trauma (2009) 0.81
Spontaneous virologic suppression in HIV controllers is independent of delayed-type hypersensitivity test responsiveness. AIDS Res Ther (2012) 0.80
Palliative HIV care: opportunities for biomedical and behavioral change. Curr HIV/AIDS Rep (2014) 0.79
Hospital-acquired device-associated infections at a deployed military hospital in Iraq. J Trauma (2009) 0.77
Coccidioidal meningitis after liver transplantation in a nonendemic region: a case report. Transplantation (2006) 0.76
Identification of HIV infection-related DNA methylation sites and advanced epigenetic aging in HIV+, treatment-naïve U.S. veterans. AIDS (2016) 0.75
Risk factors for AIDS-defining illnesses among a population of poorly adherent people living with HIV/AIDS in Atlanta, Georgia. AIDS Care (2015) 0.75
Development of dual-class antiretroviral drug resistance in a child coinfected with HIV and tuberculosis: a case report from KwaZulu-Natal, South Africa. J Trop Pediatr (2008) 0.75
Oral microbiome in HIV-associated periodontitis. Medicine (Baltimore) (2017) 0.75
Differences in expression of gut-homing receptors on CD4+ T cells in black and white HIV-negative men who have sex with men. AIDS (2016) 0.75
Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure. J Acquir Immune Defic Syndr (2017) 0.75
A commitment contract to achieve virologic suppression in poorly adherent patients with HIV/AIDS. AIDS (2017) 0.75
HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer. J Acquir Immune Defic Syndr (2017) 0.75
Correction: Coadministration of Lopinavir/Ritonavir and Rifampicin in HIV and Tuberculosis Co-Infected Adults in South Africa. PLoS One (2013) 0.75
Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020. Emerg Infect Dis (2020) 0.75